ZOOZ Strategy Ltd. (ZOOZ) Stock Analysis
ZOOZ Strategy Ltd.
▾ What's in the 27/100 risk score? (higher = riskier)
Contributions (weight × component score) sum to the total. This near-term score now includes fundamental health (leverage, FCF trend). It excludes the Altman Z score, whose retained-earnings input this filer does not report separately. See the Financial Health section for the full balance-sheet read.
How to read ZOOZ (speculative micro-cap)
No model can pin a precise fair value on a company this small — but that does not mean there is nothing to learn. The useful questions are what the price is betting on, and whether the company can survive long enough to deliver it.
-
1
Reverse-DCF — what growth the price assumes ↓
The single most useful number here: it backs out the growth the market is paying for. If that figure is "historically unprecedented," the price is running on hype, not fundamentals.
-
2
Cash runway ↓
A pre-profit micro-cap lives or dies on whether it can fund itself to profitability before running out of money and diluting you.
-
3
The raw financial statements + the 10-K ↓
At this scale, the actual numbers, insider ownership, and share-count trend tell you more than any ratio.
A discounted-cash-flow model can only discount POSITIVE cash flows. ZOOZ's free cash flow is currently negative — it's reinvesting / still pre-profit — so a forward DCF can't produce a meaningful number. That's a property of the model, not missing data; the full financials and story are below.
What to use instead: This is exactly where the Reverse-DCF earns its keep: it shows the growth the market is ALREADY pricing in, so you can judge whether that's achievable. Pair it with the EV/Sales peer lens, the Rule-of-40 read, and the cash-runway section — the right tools for a pre-profit company.
This note is only about the single DCF fair-value number — ZOOZ's full financial statements, health scores, and written analysis are all below.
How to read a company this small
ZOOZ is too small and/or too volatile for the valuation lenses we use on larger, more stable companies. The numbers shown below should be taken as rough orientation only.
- Latest annual revenue $247K — too small for meaningful growth percentages
Growth percentages on tiny revenue bases (1000% going from $200K to $2M is not predictive). P/E and ROE swing wildly with small earnings changes. Peer comparisons fail because there often aren't comparable companies at this scale.
Start with the Reverse-DCF above — it backs out the growth the price is betting on; if that figure is "historically unprecedented," the price is running on hype, not fundamentals. Then the cash runway (can it fund itself to profitability before diluting you?). Then the raw Financials table and the 10-K on SEC EDGAR — at this scale, insider ownership and the share-count trend often matter more than any ratio.
Classified as Speculative Nano / Micro-cap (confidence 80%). Disagree? An admin can override via the post edit screen.
Quality & solvency checks
Cheap stocks can be cheap for a reason. These screens warn when a low valuation comes paired with structural fragility.
Why it matters: Cheap-looking stocks (low P/E or P/B) often have low Z-scores because the market knows the company is dying. Z-score warns you before you fall into a value trap.
Reference: > 3.0 = safe zone · 1.81–3.0 = grey zone · < 1.81 = distress zone
Full explanation →
The Z-score needs working capital, retained earnings, EBIT, sales and total assets from the latest balance sheet, and at least one of those isn't reported in machine-readable form here — common for foreign private issuers. We leave it blank rather than compute a distress verdict from an estimated input. It doesn't affect the reported figures in the financial tables below.
Why it matters: High score = fundamentals improving. Low score = deteriorating. Especially powerful for filtering cheap stocks: cheap + high F-score historically outperforms; cheap + low F-score is often a value trap.
Reference: 7–9 = strong · 4–6 = mediocre · 0–3 = weak
Full explanation →
▾ The checks — what passed, what didn't (and what we couldn't measure)
-
✗ Positive net incomeNet income -$55.6M in FY2025.Why this matters: Does the company actually earn a profit? Sustained losses eventually force it to raise money — diluting you — or take on debt.
-
✗ Positive operating cash flowOperating cash flow -$13.8M (was -$9.9M the prior year).Why this matters: Profit can be an accounting figure; cash from running the business is harder to fake. Negative operating cash flow means the core business consumes cash and must be funded externally.
-
✓ Cash flow backs up reported profitOperating cash flow -$13.8M vs net income -$55.6M.
-
✓ Return on assets improvingReturn on assets -45.4% vs -85.6% a year ago.
-
✓ Debt load (vs assets)The filing reports no interest-bearing debt in either year (total assets $122.6M).
-
✓ Short-term liquidity (current ratio)Current ratio 9.85x vs 2.05x a year ago.
-
✗ Share count (dilution)Share count rose 488.8% (0.0M → 0.1M year-over-year).Why this matters: Issuing lots of new shares splits the pie into more pieces, shrinking your slice. Stable or falling share count protects existing owners.
-
✗ Pricing power (gross margin)Gross margin -1,159.5% vs -46.7% a year ago.Why this matters: Rising gross margin means stronger pricing power or lower input costs — a sign of competitive strength. Falling margin signals pressure.
-
✗ Sales per asset (asset turnover)Asset turnover 0.00x vs 0.08x a year ago.Why this matters: Asset turnover measures how much revenue each dollar of assets generates. Rising = more productive use of the asset base.
Missing data is never counted as a pass or a fail — it's shown as n/a and excluded from the denominator. Each check compares the company against its own prior year.
Plain English: the company holds about $27M in cash and is burning roughly $14M/year in operations. At that pace, the cash lasts 24 mo before it must raise capital (diluting shareholders), take on debt, or cut spending.
Assumes constant burn and ignores financing/asset sales. For pre-profit biotech and growth companies, this matters more than a DCF — a great drug pipeline is worthless if they run out of money before approval.
The market likely discounts the stock due to its consistently negative net income and operating cash flow over the past five years. The primary quantifiable risk is the company's inability to generate positive operating cash flow, which is crucial for sustainable operations.
As of 3 months ago
Anatomy of a share
What you're buying per share. Bars are at the same scale so you can see the relative size of revenue, costs, cash flow, and debt — not just read them in a table.
What you actually need to decide
Every stock price is a disagreement. Here's the single thing that must go right for the bulls, the single thing that breaks the thesis, and the concrete signposts to watch so you can update your view as real results arrive.
- Positive operating cash flow in future filings
- Improvement in net income towards profitability
- Disclosure of specific product or market expansion initiatives
The trend, in plain numbers (FY2024 → FY2025, latest reported)
Straight from the financial statements — no model, no opinion. For a small or unprofitable company, the direction of these numbers usually tells you more than any single valuation.
- Revenue fell -76% to $247K.
- Free cash flow is negative at -$20.6M — the cash burn widened vs last year.
- Gross margin shrank to -1,160% (-1,113 pts).
- Still unprofitable at -$55.6M — loss widening.
Nothing was clearly improving year-over-year.
Management & Leadership
Limited executive data available for ZOOZ Strategy Ltd. The company's leadership structure and key executives are not provided in the current data sources.
What They Make
ZOOZ Strategy Ltd. operates in the Industrials sector, specifically within Misc Industrial & Commercial Machinery & Equipment. The company's specific products and customer base are not detailed in the provided description.
End Markets
Why Is It Priced Like This?
What we use instead: earnings (P/E, EV/EBIT), book value (P/B) — computed from the figures this company does report, shown in the sections below. Those numbers are unaffected by the missing cash-flow data.
The market prices ZOOZ at a 34.6% discount, likely reflecting concerns over its fundamental health signals. Specifically, the company has reported negative net income and negative operating cash flow for the latest period and the past five years, indicating a lack of profitability and cash generation. The market may also be assigning value to potential future product developments or market expansions within the industrial machinery sector, which are not captured by the backward-looking model.
Business Model & Valuation
How They Make Money
The company has negative operating cash flow and likely funds its operations through equity raises or debt, as no dividend or buyback information is available.
Growth / Revenue DCF
Negative free cash flow: revenue/margin growth model used - standard FCF DCF is unreliable for companies still scaling.
Show advanced inputs
| Revenue Growth | 15.0% |
What this model does NOT do: this is a consolidated owner-earnings FCF model. Standalone segment assumptions: none. It does not project its revenue segments independently; their combined effect is embedded in the historical revenue and cash-flow trend the model extrapolates. The calculator above can only approximate a segment's impact through the single consolidated growth rate — it cannot model any one line separately. For a true segment-level view, build a separate model from the company's segment disclosures.
Maturity & Competitive Position
The company has reported negative net income and operating cash flow for the latest period and the past five years.
Geography & Markets
Geographic mix data is not available for ZOOZ Strategy Ltd. The company's primary regions of operation are not specified in the current data sources.
Geographic Risks
Market Signals
These are timing signals, not value signals — they describe the stock's recent price behavior, not what the business is worth. Use them for the "the thesis looks good, but is now the moment?" question. Each tile below explains what it's saying.
Why it matters: Short-term contrarian indicator. Extreme readings often precede mean reversion, though not always.
Reference: 30–70 normal · >70 overbought · <30 oversold
Full explanation → (14)51.5NeutralMomentum is balanced — neither overbought nor oversold.
Why it matters: When the fast line crosses above the slow line, short-term momentum is turning up; below, turning down. A timing cue, not a value signal.
Reference: Line above signal = bullish momentum · below = bearish
Full explanation →BullishLine above signalThe fast trend is above the slow trend — short-term momentum is currently upward.
Technicals describe price, not the business. A great company can have a "bearish" tape (a buying chance) and a weak one a "bullish" tape (a trap). Pair these with the valuation and health sections above.
QUALITY
Data Quality & Risk Flags (3 notes — click to expand/collapse)
Guardrail Notes (2)
- FCF negative: revenue/margin growth model projects future cash flows from revenue trajectory.
- Illiquidity discount 25% applied (small/micro-cap — harder to exit, demand a margin).
FINANCIALS
Financial Statements (5-year tables — click to expand)
From ZOOZ Strategy Ltd.'s SEC filings (EDGAR).
Income (5yr)
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | 247,000 | -55.6M | $-0.94 |
| 2024 | 1.0M | -11.0M | $-1.09 |
| 2023 | 764,000 | -11.8M | $-1.99 |
| 2022 | — | -7.8M | $-1.51 |
| 2021 | — | -4.6M | $-2.27 |
Cash Flow (5yr)
| Year | Operating CF | CapEx | − SBC & adj. | Free Cash Flow |
|---|---|---|---|---|
| 2025 | -13.8M | 93,000 | 6.7M | -20.6M |
| 2024 | -9.9M | 67,000 | 369,000 | -10.4M |
| 2023 | -12.2M | 1.4M | 219,000 | -13.8M |
| 2022 | -10.5M | 500,000 | 1.8M | -12.8M |
| 2021 | -6.1M | 298,000 | 1.3M | -7.7M |
How we define FCF: operating cash flow − capital expenditure − stock-based compensation (owner-earnings basis — SBC is a real cost to shareholders even though it's non-cash). Latest year: -13.8M − 93,000 − 6.7M (SBC & adj.) = -20.6M. This is the same owner-earnings FCF definition the valuation model uses, though the DCF's starting value is a projected from revenue × terminal margin, not this single year.
Balance Sheet
| Total Assets | 122.6M |
| Total Liabilities | 3.4M |
| Equity | 119.2M |
Similar companies worth a look
Same sector and industry, similar fundamentals shape. Verify everything yourself — this list is computed mechanically and does not reflect our judgment about whether any of these are a good investment.